Advisory Committee on Immunization Practices (ACIP), 5197-5198 [E8-1457]

Download as PDF 5197 Federal Register / Vol. 73, No. 19 / Tuesday, January 29, 2008 / Notices Dated: January 18, 2008. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E8–1453 Filed 1–28–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–08–08AJ] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–693–5960 or send comments to CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Focus Group Testing To Effectively Plan and Tailor Cancer Prevention and Control Communication Campaigns— New—Division of Cancer Prevention and Control (DCPC), National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The mission of the CDC’s Division of Cancer Prevention and Control (DCPC) is to reduce the burden of cancer in the United States through cancer prevention, reduction of risk, early detection, better treatment, and improved quality of life for cancer survivors. Toward this end, the DCPC supports the scientific development, implementation, and evaluation of various health communication campaigns with an emphasis on specific cancer burdens. This process requires testing of messages, concepts, and materials prior to their final development and dissemination, as described in the second step of the health communication process, a scientific model developed by the U.S. Department of Health and Human Services’ National Cancer Institute to guide sound campaign development. The communication literature supports various data collection methods to conduct credible formative, concept, message, and materials testing, one of which is focus groups. The Number of respondents Type of respondents and form name purpose of focus groups is to ensure that the public and other key audiences, like health professionals, clearly understand cancer-specific information and concepts, are motivated to take the desired action, and do not react negatively to the messages. The proposed information collection will involve focus groups to assess numerous qualitative dimensions of cancer prevention and control messages, including, but not limited to, knowledge, attitudes, beliefs, behavioral intentions, information needs and sources, and compliance to recommended screening intervals. Insights gained from the focus groups will assist in the development and/or refinement of future campaign messages and materials. Respondents will include health care providers as well as members of the general public. Because communication campaigns will vary according to the type of cancer, the qualitative dimensions of the message described above, and the type of respondents, DCPC has developed a library of questions that can be tailored for use by a variety of types of focus groups. A generic clearance of the repository of questions is requested. The discussion guide for each focus group will be drawn from the list of preapproved questions. The average burden for each focus group discussion will be two hours. DCPC will conduct or sponsor up to 66 focus groups per year over a three-year period. An average of 12 respondents will participate in each focus group discussion. There are no costs to respondents except their time. The total estimated annualized burden hours are 1,663. Estimated Annualized Burden Hours: Number of responses per respondent Average burden per response (in hours) Total burden (in hours) 1,584 792 1 1 3/60 2 79 1,584 Total ................................................................................................... sroberts on PROD1PC70 with NOTICES Health care providers and general public: Screening Form ........................................................................................ Focus Group Discussion Guide ................................................................ ........................ ........................ ........................ 1,663 Dated: January 18, 2008. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E8–1456 Filed 1–28–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act VerDate Aug<31>2005 22:52 Jan 28, 2008 Jkt 214001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting for the aforementioned committee: Time and Date: 8 a.m.–6 p.m., February 27, 2008; 8 a.m.–5 p.m., February 28, 2008. Place: Centers for Disease Control and Prevention, Tom Harkin Global Communications Center, 1600 Clifton Road, NE., Building 19, Kent ‘‘Oz’’ E:\FR\FM\29JAN1.SGM 29JAN1 5198 Federal Register / Vol. 73, No. 19 / Tuesday, January 29, 2008 / Notices Nelson Auditorium, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C.1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Matters To Be Discussed: The agenda will include discussions on Influenza Vaccines; Meningococcal Conjugate Vaccine; Rabies Vaccine and Biologicals; Human Papillomavirus Vaccines; Anthrax Vaccine; Rotavirus Vaccines; Use of Vaccines during Pregnancy & Breastfeeding; Update on Vaccine Supply; General Recommendations; Japanese Encephalitis Vaccines; Immunization Safety Update; Combination Vaccines; Update on Implementation of Approach to Economic Analyses and agency updates. There may be VFC voting on the Influenza and Meningococcal Vaccines. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Antonette Hill, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., Mailstop E–05, Atlanta, Georgia 30333, Telephone (404) 639–8836, Fax (404) 639–8905. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR. sroberts on PROD1PC70 with NOTICES Dated: January 18, 2008. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–1457 Filed 1–28–08; 8:45 am] BILLING CODE 4160–18–P VerDate Aug<31>2005 22:52 Jan 28, 2008 Jkt 214001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Meeting for the aforementioned committee: Times and Dates: 8 a.m.–5 p.m., February 19, 2008 (Closed); 8 a.m.–5 p.m., February 20, 2008 (Closed) Place: Sir Francis Drake Hotel, 450 Powell Street, San Francisco, California 94102, Telephone (415) 392–7755, Fax (415) 391–8719. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broad-based research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters To Be Discussed: The meeting will convene to address matters related to the conduct of Study Section business and for the study section to consider safety and occupational healthrelated grant applications. These portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, Centers for Disease Control and Prevention, pursuant to section 10(d) Public Law 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Price Connor, PhD., NIOSH Health Scientist, 1600 Clifton Road, NE., Mailstop E–20, Atlanta, Georgia 30333, Telephone (404)498–2511, Fax (404)498–2571. PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: January 19, 2008. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–1458 Filed 1–28–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Statement of Organization, Functions and Delegation of Authority Notice is hereby given that I have delegated to the Director, Office of Refugee Resettlement, with the authority to further re-delegate, the following authority delegated to the Assistant Secretary for Children and Families by the Secretary of the Department of Health and Human Services on April 30, 2004. (a) Authority Delegated. Authority to conduct public awareness and information activities under the Trafficking Victims Protection Act of 2000 (TVPA), Public Law 106– 386, section 106(b), 22 U.S.C. 7104(b). (b) Limitations and Conditions. 1. This delegation shall be exercised under the Department’s existing delegation of authority and policy on regulations. 2. This delegation shall be exercised under financial and administrative requirements applicable to all Administration for Children and Families’ authorities. 3. The Director of the Anti-Trafficking in Persons Division must report to the Director, Office of Refugee Resettlement, and the Director, Office of Refugee Resettlement, must report to the Assistant Secretary prior to carrying out public awareness and information activities. (c) Effective Date. This delegation is effective upon date of signature. (d) Effect on Existing Delegations. None. In addition, I have affirmed and ratified any actions taken by the Director, Office of Refugee Resettlement, which involved the exercise of this authority prior to the effective date of this delegation. E:\FR\FM\29JAN1.SGM 29JAN1

Agencies

[Federal Register Volume 73, Number 19 (Tuesday, January 29, 2008)]
[Notices]
[Pages 5197-5198]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-1457]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting for the 
aforementioned committee:
    Time and Date: 8 a.m.-6 p.m., February 27, 2008; 8 a.m.-5 p.m., 
February 28, 2008.
    Place: Centers for Disease Control and Prevention, Tom Harkin 
Global Communications Center, 1600 Clifton Road, NE., Building 19, Kent 
``Oz''

[[Page 5198]]

Nelson Auditorium, Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, CDC, 
on the appropriate uses of immunizing agents. In addition, under 42 
U.S.C.1396s, the committee is mandated to establish and periodically 
review and, as appropriate, revise the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) program, along with schedules regarding the appropriate 
periodicity, dosage, and contraindications applicable to the vaccines.
    Matters To Be Discussed: The agenda will include discussions on 
Influenza Vaccines; Meningococcal Conjugate Vaccine; Rabies Vaccine and 
Biologicals; Human Papillomavirus Vaccines; Anthrax Vaccine; Rotavirus 
Vaccines; Use of Vaccines during Pregnancy & Breastfeeding; Update on 
Vaccine Supply; General Recommendations; Japanese Encephalitis 
Vaccines; Immunization Safety Update; Combination Vaccines; Update on 
Implementation of Approach to Economic Analyses and agency updates. 
There may be VFC voting on the Influenza and Meningococcal Vaccines.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Antonette Hill, Immunization 
Services Division, National Center for Immunization and Respiratory 
Diseases, CDC, 1600 Clifton Road, NE., Mailstop E-05, Atlanta, Georgia 
30333, Telephone (404) 639-8836, Fax (404) 639-8905.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the CDC and ATSDR.

    Dated: January 18, 2008.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E8-1457 Filed 1-28-08; 8:45 am]
BILLING CODE 4160-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.